OSSFF (Embla Medical hf) Growth Rank: 9 (As of Jul. 08, 2026) — 50% Above Median


OSSFF Embla Medical hf OSSFF
92 GF Score
Price $4.15
GF Value $5.32
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf Growth Rank?

Embla Medical hf OSSFF 92 Growth Rank is 9 as of Jul. 08, 2026, which is 50% above its 10-year median of 6.00. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.32. The stock has 2 warning signs investors should review.

Embla Medical hf has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Embla Medical hf Growth Rank Related Terms

OSSFF vs ABT, SYK, MDT: Growth Rank Comparison

For the Medical Devices subindustry, Embla Medical hf's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embla Medical hf Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Growth Rank distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Growth Rank falls into.


OSSFF
92GF Score
Embla Medical hf OSSFF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 9 mean?
Embla Medical hf (OSSFF) has a Growth Rank of 9 as of Jul. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Embla Medical hf and its competitors. This is 50% above median its historical median of 6.00. Over the past decade, Embla Medical hf's Growth Rank has ranged from 3.00 to 10.00.
Is Embla Medical hf's Growth Rank too high?
Embla Medical hf's current Growth Rank of 9 is 50% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Growth Rank compare to ABT and SYK?
Embla Medical hf's Growth Rank of 9 can be compared against companies in the Medical Devices & Instruments industry. Historically, Embla Medical hf's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Growth Rank is 9, which is 50% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Growth Rank of 9. The stock's GF Value™ is $5.32, compared to a current price of $4.15 — trading 22% below its estimated fair value. The current Growth Rank is 9, which is 50% above median its 10-year median of 6.00. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Growth Rank is 9 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OSSFF) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of $4.15 is trading 22% below its estimated GF Value™ of $5.32.

Key valuation signals for OSSFF:

  • Growth Rank: 9 (50% above median its 10-year median of 6.00)
  • GF Value™: $5.32 vs. price of $4.15 (22% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embla Medical hf Business Description

Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score

Get the complete analysis for OSSFF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.15
Price
$5.32
GF Value